When is cancer
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Cancer Statistics and Trends: A Comprehensive Overview
Introduction to Cancer Statistics
Cancer remains a significant public health challenge worldwide, with millions of new cases and deaths reported annually. The American Cancer Society (ACS) and other organizations compile and analyze data to provide insights into cancer incidence, mortality, and survival rates. This article synthesizes key findings from various reports to present a cohesive understanding of cancer trends over the years.
Global and National Cancer Incidence
Global Cancer Incidence in 2020
In 2020, there were an estimated 19.3 million new cancer cases globally, with female breast cancer being the most commonly diagnosed, followed by lung and prostate cancers. The most common causes of cancer death were lung, liver, and stomach cancers.
U.S. Cancer Incidence Trends
In the United States, the number of new cancer cases has shown varying trends over the years. For instance, in 2022, approximately 1.9 million new cancer cases were projected. Historical data indicate that cancer incidence rates have stabilized for women since 1999 and for men since 1995. However, specific cancers like female breast cancer have seen a slow increase in incidence.
Mortality Rates and Trends
Decline in Cancer Mortality
The overall cancer death rate in the U.S. has been declining since its peak in 1991. By 2018, the death rate had fallen by 31%, translating to 3.2 million fewer cancer deaths than if peak rates had persisted. This decline is attributed to reductions in smoking and advancements in early detection and treatment.
Specific Cancer Mortality Trends
Lung cancer mortality has seen significant declines, with the annual decrease in death rates accelerating from 3.1% to 5.5% in men and from 1.8% to 4.4% in women between 2009 and 2018. Conversely, mortality rates for liver, pancreas, and uterine corpus cancers have been increasing.
Survival Rates and Disparities
Improvements in Survival Rates
Survival rates for certain cancers have improved markedly. For example, the 3-year relative survival rate for localized-stage lung cancer increased from 21% to 31% between 2004 and 2018. Similarly, the 2-year relative survival for non-small cell lung cancer (NSCLC) increased from 34% to 42% between 2009 and 2016.
Socioeconomic and Racial Disparities
Despite overall progress, significant disparities in cancer outcomes persist. Black men and women experience higher cancer incidence and poorer survival rates compared to their white counterparts. Additionally, socioeconomic inequalities are evident, with poorer counties experiencing higher mortality rates for preventable cancers like cervical and lung cancer.
Conclusion
The fight against cancer has seen substantial progress, particularly in reducing mortality rates and improving survival for certain cancers. However, challenges remain, including rising incidence rates for some cancers and persistent disparities in outcomes across different demographic groups. Continued investment in cancer research, early detection, and equitable healthcare access is crucial to further accelerate progress and reduce the global cancer burden.
Sources and full results
Most relevant research papers on this topic